-
Adaptive designs for Phase II oncology trials
Meinhard Kieser, Stefan Englert, Geraldine Rauch
Commentary: Clinical Investigation
-
Adaptive designs for Phase II oncology trials
Meinhard Kieser, Stefan Englert, Geraldine Rauch
Commentary: Clinical Investigation
-
Adaptive designs for Phase II oncology trials
Meinhard Kieser, Stefan Englert, Geraldine Rauch
Commentary: Clinical Investigation
-
Adaptive designs for Phase II oncology trials
Meinhard Kieser, Stefan Englert, Geraldine Rauch
Commentary: Clinical Investigation
-
Adaptive designs for Phase II oncology trials
Meinhard Kieser, Stefan Englert, Geraldine Rauch
Commentary: Clinical Investigation
-
Adaptive designs for Phase II oncology trials
Meinhard Kieser, Stefan Englert, Geraldine Rauch
Commentary: Clinical Investigation
-
Adaptive designs for Phase II oncology trials
Meinhard Kieser, Stefan Englert, Geraldine Rauch
Commentary: Clinical Investigation
-
Adaptive designs for Phase II oncology trials
Meinhard Kieser, Stefan Englert, Geraldine Rauch
Commentary: Clinical Investigation
-
Exploring the challenges, impacts and implications of risk-based monitoring
Richard C Zink
Commentary: Clinical Investigation
-
Exploring the challenges, impacts and implications of risk-based monitoring
Richard C Zink
Commentary: Clinical Investigation
-
Exploring the challenges, impacts and implications of risk-based monitoring
Richard C Zink
Commentary: Clinical Investigation
-
Exploring the challenges, impacts and implications of risk-based monitoring
Richard C Zink
Commentary: Clinical Investigation
-
Exploring the challenges, impacts and implications of risk-based monitoring
Richard C Zink
Commentary: Clinical Investigation
-
Exploring the challenges, impacts and implications of risk-based monitoring
Richard C Zink
Commentary: Clinical Investigation
-
Exploring the challenges, impacts and implications of risk-based monitoring
Richard C Zink
Commentary: Clinical Investigation
-
Exploring the challenges, impacts and implications of risk-based monitoring
Richard C Zink
Commentary: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
Alitretinoin for the treatment of chronic hand eczema: clinical rationale
Vivian Y Shi, Raja K Sivamani & Howard Maibach
Review Article: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
A close look at trachoma control and the challenges that district programs pose
Sheila West
Editorial: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Sustained and rapid virological responses in hepatitis C clinical trials
Akihito Tsubota, Tomomi Furihata, Yoshihiro Matsumoto, Kan Chiba
Clinical Trail Prospective: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Etanercept for the treatment of axial spondyloarthritis
I-H Song, J Sieper
Review: Clinical Trail Outcomes: Clinical Investigation
-
Noninferiority trials: clinical understandings and misunderstandings
John H Powers,Thomas R Fleming
Editorial: Clinical Investigation
-
Noninferiority trials: clinical understandings and misunderstandings
John H Powers,Thomas R Fleming
Editorial: Clinical Investigation
-
Noninferiority trials: clinical understandings and misunderstandings
John H Powers,Thomas R Fleming
Editorial: Clinical Investigation
-
Noninferiority trials: clinical understandings and misunderstandings
John H Powers,Thomas R Fleming
Editorial: Clinical Investigation
-
Noninferiority trials: clinical understandings and misunderstandings
John H Powers,Thomas R Fleming
Editorial: Clinical Investigation
-
Noninferiority trials: clinical understandings and misunderstandings
John H Powers,Thomas R Fleming
Editorial: Clinical Investigation
-
Noninferiority trials: clinical understandings and misunderstandings
John H Powers,Thomas R Fleming
Editorial: Clinical Investigation
-
Noninferiority trials: clinical understandings and misunderstandings
John H Powers,Thomas R Fleming
Editorial: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2: Iss 9
Acknowledgements: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation
-
Psoriasis, a proof-of-principle condition for immune-mediated inflammatory disorders: perspectives toward optimal clinical trial design
Kristen Corey, Peter Mattei, Neil Houston, Paul W Tebbey, Alan Menter, Peter CM van de Kerkhof, Alexa Boer Kimball
Clinical Trail Perspective: Clinical Investigation